Related Experiment Video
Updated: Aug 6, 2026

Modification of the Treatment Methods for Wasting Marmoset Syndrome with Tranexamic Acid and Supportive Measures
Published on: July 12, 2024
Refeeding Syndrome Induced by Fursultiamine Infusion in Wernicke Encephalopathy: A Case Report
Shotaro Ishikawa1, Satoshi Ota2, Natsuko Nakazaki3
1Department of Internal Medicine, Kanto Rosai Hospital, Japan.
Abstract:
Wernicke encephalopathy is caused by thiamine deficiency, and treatment with high-dose thiamine is recommended for its management. We herein report the case of an older adult woman who developed refeeding syndrome after receiving intravenous fursultiamine. Although the patient's oral food intake was restricted to prevent refeeding syndrome, the total caloric load, including glucose contained in fursultiamine, exceeded the recommended amount. This case demonstrates that the caloric contribution of glucose present in fursultiamine should not be overlooked when treating Wernicke encephalopathy with high-dose parenteral fursultiamine.
Related Concept Videos
Hepatic Encephalopathy
Rocky Mountain Spotted Fever
